Concepedia
Statistics
Publications
8
Citations
2K
H-Index
Active since
2017
Affiliations
University of Bristol(Current)
King's College London
University of Oxford
University of Nottingham
NIHR Oxford Musculoskeletal Biomedical Research Centre
Hemant Maraj is an author at University of Bristol specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.
Publications per year
2017–2024
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
1–5 of 8